VSTM2A interacts with the extracellular domain of LRP6 and inhibits LRP6 phosphorylation, thereby inducing its lysosomal degradation, and suppressing colorectal cancer progression (Dong et al., 2019). The gene discussed is VSTM2A; the disease is colorectal cancer.